GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanxi Jinbo Bio pharmaceutical Co Ltd (BJSE:832982) » Definitions » Capital Expenditure

Shanxi Jinbo Bio pharmaceutical Co (BJSE:832982) Capital Expenditure : ¥-272.03 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Shanxi Jinbo Bio pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shanxi Jinbo Bio pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-150 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-272.03 Mil.

Shanxi Jinbo Bio pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Shanxi Jinbo Bio pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Jinbo Bio pharmaceutical Co Capital Expenditure Chart

Shanxi Jinbo Bio pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.48 -103.91 -100.01 -151.92 -155.60

Shanxi Jinbo Bio pharmaceutical Co Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.21 -20.72 -36.96 -64.72 -149.64

Shanxi Jinbo Bio pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-272.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanxi Jinbo Bio pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanxi Jinbo Bio pharmaceutical Co Ltd (BJSE:832982) » Definitions » Capital Expenditure
Comparable Companies
SZSE:002252 SZSE:300122 SZSE:002653 SHSE:688578 SHSE:600161 SZSE:300759 SHSE:688336 SHSE:688278 SZSE:002821 SZSE:002007 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 18, Jinbo Street, Tanghuai Park, Comprehensive Reform Demonstration Zone, Shanxi, Taiyuan, CHN, 030032
Website
http://www.sxjbswyy.com
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.

Shanxi Jinbo Bio pharmaceutical Co Headlines

No Headlines